Vittal Vasista, Chief Financial Officer at REGENXBIO Inc. (RGNX), sold 15,000 shares at $40.11 ($601K) on 2020-04-24, disclosed to the SEC on 2020-04-27.
Open-market sale of $601k RGNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.00 | 3,000 | $120K | 20.0% |
| 2 | $40.11 | 12,000 | $481K | 80.0% |
| Total | $40.09 avg | 15,000 | $601K | 100% |
| Filing → |
| RGNX | SELL | 2022-08-03 | $75K | — | Filing → |
| RGNX | SELL | 2022-07-15 | $274K | — | Filing → |
| RGNX | SELL | 2021-01-20 | $13K | — | Filing → |